Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-030517

Chief Business Officer acquired 2,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2022-09-01 Grant or award +1,010 $25.98 $26,240 98,534 D
Robb Gary Charles Chief Business Officer 2022-09-01 Grant or award +1,010 99,544 D
Loading xslF345X03/doc4.xml…